Synthesis of Novel Compounds for Leishmaniasis
Abstract
Leishmaniasis is a neglected tropical disease (NTD) affecting over 90 countries today. Visceral Leishmaniasis, is the most serious form of Leishmaniasis. Current treatment is shown to be toxic such as Liposomal amphotericin and no vaccine or medicine prevents or reduces infection. The project is partnered with Drugs for Neglected Diseases Initiative (DNDi). The purpose of this project was to use the hit compound DNDI0003202883 and alter it by making little modifications around the aromatic ring and studying the structure-activity relationship (SAR) of the compound. To do this, the carboxylic acid group was altered in a synthetic reaction and ran through a TLC test to check the number of potential products there was in a reaction. If the compound had more than one potential product, it was put through column chromatography to purify it. Then the purified compound is run through an infrared (IR) spectroscopy to confirm that the product is different from the amine. Then, the final compounds were sent to our collaborators for biological testing. This testing has brought many opportunities to find a treatment for Leishmaniasis that will increase the availability of nontoxic treatments to the general public.
Synthesis of Novel Compounds for Leishmaniasis
Leishmaniasis is a neglected tropical disease (NTD) affecting over 90 countries today. Visceral Leishmaniasis, is the most serious form of Leishmaniasis. Current treatment is shown to be toxic such as Liposomal amphotericin and no vaccine or medicine prevents or reduces infection. The project is partnered with Drugs for Neglected Diseases Initiative (DNDi). The purpose of this project was to use the hit compound DNDI0003202883 and alter it by making little modifications around the aromatic ring and studying the structure-activity relationship (SAR) of the compound. To do this, the carboxylic acid group was altered in a synthetic reaction and ran through a TLC test to check the number of potential products there was in a reaction. If the compound had more than one potential product, it was put through column chromatography to purify it. Then the purified compound is run through an infrared (IR) spectroscopy to confirm that the product is different from the amine. Then, the final compounds were sent to our collaborators for biological testing. This testing has brought many opportunities to find a treatment for Leishmaniasis that will increase the availability of nontoxic treatments to the general public.